Serum biomarkers of habitual coffee consumption may provide insight into the mechanism underlying the association between coffee consumption and colorectal cancer

American Journal of Clinical Nutrition

Volumn 101, Issue 5, 2015, Pages 1000-1011

  Guertin, Kristin A ^a   Loftfield, Erikka ^a   Boca, Simina M ^b   Sampson, Joshua N ^a   Moore, Steven C ^a   Xiao, Qian ^a   Huang, Wen Yi ^a   Xiong, Xiaoqin ^c   Freedman, Neal D ^a   Cross, Amanda J ^d   Sinha, Rashmi ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^c INFORMATION MANAGEMENT SERVICES INC   (United States)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Coffee; Colorectal cancer; Dietary intake; Metabolites; Metabolomics

Indexed keywords

1 METHYLXANTHINE; BIOLOGICAL MARKER; CAFFEINE; CATECHOL DERIVATIVE; GLYCINE DERIVATIVE; PARAXANTHINE; QUININE SULFATE; THEOBROMINE; THEOPHYLLINE; TRIGONELLINE; COFFEE;

ALCOHOL CONSUMPTION; ARTICLE; BIODEGRADATION; COFFEE; COFFEE CONSUMPTION; COLORECTAL CANCER; COMPARATIVE STUDY; CONTROLLED STUDY; DIETARY INTAKE; DISEASE ASSOCIATION; FEMALE; FOOD FREQUENCY QUESTIONNAIRE; HUMAN; MAJOR CLINICAL STUDY; MALE; METABOLOMICS; SMOKING; AGED; BLOOD; CASE CONTROL STUDY; CLINICAL TRIAL; COLORECTAL NEOPLASMS; FEEDING BEHAVIOR; MASS FRAGMENTOGRAPHY; MIDDLE AGED; MULTICENTER STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; STATISTICAL MODEL;

AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; COFFEE; COLORECTAL NEOPLASMS; FOOD HABITS; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; LOGISTIC MODELS; METABOLOMICS; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS;

EID: 84929658789     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.114.096099     Document Type: Article

References (67)

1. Farah A, Monteiro M, Donangelo C, Lafay S. Chlorogenic acids from green coffee extract are highly bioavailable in humans. J Nutr 2008; 138:2309-15.
2. Nkondjock A. Coffee consumption and the risk of cancer: an overview. Cancer Lett 2009;277:121-5.
3. Arab L. Epidemiologic evidence on coffee and cancer. Nutr Cancer 2010;62:271-83.
4. Je Y, Giovannucci E. Coffee consumption and total mortality: a metaanalysis of twenty prospective cohort studies. Br J Nutr 2014;111: 1162-73.
5. Malerba S, Turati F, Galeone C, Pelucchi C, Verga F, La Vecchia C, Tavani A. A meta-analysis of prospective studies of coffee consumption and mortality for all causes, cancers and cardiovascular diseases. Eur J Epidemiol 2013;28:527-39.
6. Crippa A, Discacciati A, Larsson SC, Wolk A, Orsini N. Coffee consumption and mortality from all causes, cardiovascular disease, and cancer: a dose-response meta-analysis. Am J Epidemiol 2014;180: 763-75.
7. Freedman ND, Park Y, Abnet CC, Hollenbeck AR, Sinha R. Association of coffee drinking with total and cause-specific mortality. N Engl J Med 2012;366:1891-904.
8. Liu R, Guo X, Park Y, Huang X, Sinha R, Freedman ND, Hollenbeck AR, Blair A, Chen H. Caffeine intake, smoking, and risk of Parkinson disease in men and women. Am J Epidemiol 2012;175:1200-7.
9. Je Y, Giovannucci E. Coffee consumption and risk of endometrial cancer: findings from a large up-to-date meta-analysis. Int J Cancer 2012;131:1700-10.
10. Gunter MJ, Schaub JA, Xue X, Freedman ND, Gaudet MM, Rohan TE, Hollenbeck AR, Sinha R. A prospective investigation of coffee drinking and endometrial cancer incidence. Int J Cancer 2012;131: 530-6.
11. Lai GY, Weinstein SJ, Albanes D, Taylor PR, McGlynn KA, Virtamo J, Sinha R, Freedman ND. The association of coffee intake with liver cancer incidence and chronic liver disease mortality in male smokers. Br J Cancer 2013;109:1344-51.
12. Sang LX, Chang B, Li XH, Jiang M. Consumption of coffee associated with reduced risk of liver cancer: a meta-analysis. BMC Gastroenterol 2013;13:34.
13. Ferrucci LM, Cartmel B, Molinaro AM, Leffell DJ, Bale AE, Mayne ST. Tea, coffee, and caffeine and early-onset basal cell carcinoma in a case-control study. Eur J Cancer Prev 2014;23:296-302.
14. Song F, Qureshi AA, Han J. Increased caffeine intake is associated with reduced risk of basal cell carcinoma of the skin. Cancer Res 2012;72:3282-9.
15. Sinha R, Cross AJ, Daniel CR, Graubard BI, Wu JW, Hollenbeck AR, Gunter MJ, Park Y, Freedman ND. Caffeinated and decaffeinated coffee and tea intakes and risk of colorectal cancer in a large prospective study. Am J Clin Nutr 2012;96:374-81.
16. Howlader N, Noone AM, Krapcho M, Garshell J, Neyman N, Altekruse SF, Kosary CL, Yu M, Ruhl J, Tatalovich Z, et al., editors. SEER Cancer Statistics Review, 1975-2010. Version current November 2012 [cited 2014 Nov 4]. Available from: http://seer.cancer.gov/csr/1975-2010/.
17. Galeone C, Turati F, La Vecchia C, Tavani A. Coffee consumption and risk of colorectal cancer: a meta-analysis of case-control studies. Cancer Causes Control 2010;21:1949-59.
18. Je Y, Liu W, Giovannucci E. Coffee consumption and risk of colorectal cancer: a systematic review and meta-analysis of prospective cohort studies. Int J Cancer 2009;124:1662-8.
19. Yu X, Bao Z, Zou J, Dong J. Coffee consumption and risk of cancers: a meta-analysis of cohort studies. BMC Cancer 2011;11:96.
20. Zhang X, Albanes D, Beeson WL, van den Brandt PA, Buring JE, Flood A, Freudenheim JL, Giovannucci EL, Goldbohm RA, Jaceldo-Siegl K, et al. Risk of colon cancer and coffee, tea, and sugar-sweetened soft drink intake: pooled analysis of prospective cohort studies. J Natl Cancer Inst 2010;102:771-83.
21. Kot M, Daniel WA. The relative contribution of human cytochrome P450 isoforms to the four caffeine oxidation pathways: an in vitro comparative study with cDNA-expressed P450s including CYP2C isoforms. Biochem Pharmacol 2008;76:543-51.
22. Cornelis MC, Byrne EM, Esko T, Nalls MA, Ganna A, Paynter N, Monda KL, Amin N, Fischer K, Renstrom F, et al. Genome-wide metaanalysis identifies six novel loci associated with habitual coffee consumption. Mol Psychiatry 2014 Oct 7 (Epub ahead of print; DOI:10.1038/mp.2014.107).
23. Gonthier MP, Remesy C, Scalbert A, Cheynier V, Souquet JM, Poutanen K, Aura AM. Microbial metabolism of caffeic acid and its esters chlorogenic and caftaric acids by human faecal microbiota in vitro. Biomed Pharmacother 2006;60:536-40.
24. Oresic M. Metabolomics, a novel tool for studies of nutrition, metabolism and lipid dysfunction. Nutr Metab Cardiovasc Dis 2009;19:816-24.
25. Guertin KA, Moore SC, Sampson JN, Huang WY, Xiao Q, Stolzenberg-Solomon RZ, Sinha R, Cross AJ. Metabolomics in nutritional epidemiology: identifying metabolites associated with diet and quantifying their potential to uncover diet-disease relations in populations. Am J Clin Nutr 2014;100:208-17.
26. Cross AJ, Moore SC, Boca S, Huang WY, Xiong X, Stolzenberg- Solomon R, Sinha R, Sampson JN. A prospective study of serum metabolites and colorectal cancer risk. Cancer 2014;120:3049-57.
27. Gohagan JK, Prorok PC, Hayes RB, Kramer BS. The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status. Control Clin Trials 2000;21(6 Suppl):251S-72S.
28. Prorok PC, Andriole GL, Bresalier RS, Buys SS, Chia D, Crawford ED, Fogel R, Gelmann EP, Gilbert F, Hasson MA, et al. Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial. Control Clin Trials 2000;21(6 Suppl):273S-309S.
29. World Health Organization. International Classification of Diseases for Oncology. 3rd ed (ICD-O-3). 2000 [cited 2014 Nov 4]. Available from: http://www.who.int/classifications/icd/adaptations/oncology/en/.
30. Willett WC, Sampson L, Stampfer MJ, Rosner B, Bain C, Witschi J, Hennekens CH, Speizer FE. Reproducibility and validity of a semiquantitative food frequency questionnaire. Am J Epidemiol 1985;122: 51-65.
31. Block G, Hartman AM, Dresser CM, Carroll MD, Gannon J, Gardner L. A data-based approach to diet questionnaire design and testing. Am J Epidemiol 1986;124:453-69.
32. Tippett KS, Cypell YS. Design and operation: The continuing survey of food intakes by individuals and the diet and health knowledge survey, 1994-96. Nationwide Food Surveys Report No. 96-1. Springfield (VA): US Department of Agriculture, Agricultural Research Service; 1997. p. 1-139.
33. Subar AF, Thompson FE, Kipnis V, Midthune D, Hurwitz P, McNutt S, McIntosh A, Rosenfeld S. Comparative validation of the Block, Willett, and National Cancer Institute food frequency questionnaires: The Eating at America's Table Study. Am J Epidemiol 2001;154:1089-99.
34. Evans AM, DeHaven CD, Barrett T, Mitchell M, Milgram E. Integrated, nontargeted ultrahigh performance liquid chromatography/electrospray ionization tandem mass spectrometry platform for the identification and relative quantification of the small-molecule complement of biological systems. Anal Chem 2009;81:6656-67.
35. Suhre K, Shin SY, Petersen AK, Mohney RP, Meredith D, Wagele B, Altmaier E, CARDIoGRAM, Deloukas P, Erdmann J, et al. Human metabolic individuality in biomedical and pharmaceutical research. Nature 2011;477:54-60.
36. Sha W, da Costa KA, Fischer LM, Milburn MV, Lawton KA, Berger A, Jia W, Zeisel SH. Metabolomic profiling can predict which humans will develop liver dysfunction when deprived of dietary choline. FASEB J 2010;24:2962-75.
37. Hayes RB, Reding D, Kopp W, Subar AF, Bhat N, Rothman N, Caporaso N, Ziegler RG, Johnson CC, Weissfeld JL, et al. Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial. Control Clin Trials 2000;21(6 Suppl): 349-55.
38. Sampson JN, Boca SM, Shu XO, Stolzenberg-Solomon RZ, Matthews CE, Hsing AW, Tan YT, Ji BT, Chow WH, Cai Q, et al. Metabolomics in epidemiology: sources of variability in metabolite measurements and implications. Cancer Epidemiol Biomarkers Prev 2013;22:631-40.
39. Dominianni C, Huang WY, Berndt S, Hayes RB, Ahn J. Prospective study of the relationship between coffee and tea with colorectal cancer risk: The PLCO Cancer Screening Trial. Br J Cancer 2013;109:1352-9.
40. Grobbee DE, Rimm EB, Giovannucci E, Colditz G, Stampfer M, Willett W. Coffee, caffeine, and cardiovascular disease in men. N Engl J Med 1990;323:1026-32.
41. Gross G, Jaccaud E, Huggett AC. Analysis of the content of the diterpenes cafestol and kahweol in coffee brews. Food Chem Toxicol 1997;35:547-54.
42. Urgert R, van der Weg G, Kosmeijer-Schuil TG, van de Bovenkamp P, Hovenier R, Katan MB. Levels of the cholesterol-elevating diterpenes cafestol and kahweol in various coffee brews. J Agric Food Chem 1995;43:2167-72.
43. Alves RC, Almeida IM, Casal S, Oliveira MB. Isoflavones in coffee: influence of species, roast degree, and brewing method. J Agric Food Chem 2010;58:3002-7.
44. Farah A. Coffee constituents. In: Chu Y-F, editor. Coffee: emerging health effects and disease prevention. Oxford (United Kingdom):Wiley- Blackwell; 2012. p. 21-58.
45. Rothwell JA, Fillatre Y, Martin JF, Lyan B, Pujos-Guillot E, Fezeu L, Hercberg S, Comte B, Galan P, Touvier M, et al. New biomarkers of coffee consumption identified by the non-targeted metabolomic profiling of cohort study subjects. PLoS ONE 2014;9:e93474.
46. Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000;28:27-30.
47. Kanehisa M, Goto S, Sato Y, Kawashima M, Furumichi M, Tanabe M. Data, information, knowledge and principle: back to metabolism in KEGG. Nucleic Acids Res 2014;42:199-205.
48. Ludwig IA, Paz de Pena M, Concepcion C, Alan C. Catabolism of coffee chlorogenic acids by human colonic microbiota. Biofactors 2013;39:623-32.
49. Gonthier MP, Verny MA, Besson C, Remesy C, Scalbert A. Chlorogenic acid bioavailability largely depends on its metabolism by the gut microflora in rats. J Nutr 2003;133:1853-9.
50. Adamson RH, Bridges JW, Evans ME, Williams RT. Species differences in the aromatization of quinic acid in vivo and the role of gut bacteria. Biochem J 1970;116:437-43.
51. Reiner AM. Metabolism of aromatic compounds in bacteria. Purification and properties of the catechol-forming enzyme, 3, 5-cyclohexadiene-1, 2- diol-1-carboxylic acid (NAD +) oxidoreductase (decarboxylating). J Biol Chem 1972;247:4960-5.
52. Lang R, Dieminger N, Beusch A, Lee YM, Dunkel A, Suess B, Skurk T, Wahl A, Hauner H, Hofmann T. Bioappearance and pharmacokinetics of bioactives upon coffee consumption. Anal Bioanal Chem 2013;405:8487-503.
53. Rechner AR, Smith MA, Kuhnle G, Gibson GR, Debnam ES, Srai SK, Moore KP, Rice-Evans CA. Colonic metabolism of dietary polyphenols: influence of structure on microbial fermentation products. Free Radic Biol Med 2004;36:212-25.
54. van Beek, S, Priest FG. Decarboxylation of substituted cinnamic acids by lactic acid bacteria isolated during malt whisky fermentation. Appl Environ Microbiol 2000;66:5322-8.
55. Rodriguez H, Landete JM, de las Rivas, B, Munoz R. Metabolism of food phenolic acids by Lactobacillus plantarum CECT 748(T). Food Chem 2008;107:1393-8.
56. Hoskins JA, Holliday SB, Greenway AM. The metabolism of cinnamic acid by healthy and phenylketonuric adults: a kinetic study. Biomed Mass Spectrom 1984;11:296-300.
57. Pettersen JE, Jellum E. The identification and metabolic origin of 2-furoylglycine and 2, 5-furandicarboxylic acid in human urine. Clin Chim Acta 1972;41:199-207.
58. Ginz M, Engelhardt UH. Identification of proline-based diketopiperazines in roasted coffee. J Agric Food Chem 2000;48:3528-32.
59. Allred KF, Yackley KM, Vanamala J, Allred CD. Trigonelline is a novel phytoestrogen in coffee beans. J Nutr 2009;139:1833-8.
60. Singh N, Gurav A, Sivaprakasam S, Brady E, Padia R, Shi H, Thangaraju M, Prasad PD, Manicassamy S, Munn DH, et al. Activation of Gpr109a, receptor for niacin and the commensal metabolite butyrate, suppresses colonic inflammation and carcinogenesis. Immunity 2014;40:128-39.
61. Rao SS, Welcher K, Zimmerman B, Stumbo P. Is coffee a colonic stimulant? Eur J Gastroenterol Hepatol 1998;10:113-8.
62. Merighi S, Benini A, Mirandola P, Gessi S, Varani K, Simioni C, Leung E, Maclennan S, Baraldi PG, Borea PA. Caffeine inhibits adenosine-induced accumulation of hypoxia-inducible factor-1alpha, vascular endothelial growth factor, and interleukin-8 expression in hypoxic human colon cancer cells. Mol Pharmacol 2007;72:395-406.
63. Wiernik PH, Paietta E, Goloubeva O, Lee SJ, Makower D, Bennett JM, Wade JL, Ghosh C, Kaminer LS, Pizzolo J, et al. Phase II study of theophylline in chronic lymphocytic leukemia: a study of the Eastern Cooperative Oncology Group (E4998). Leukemia 2004;18:1605-10.
64. Gamage N, Barnett A, Hempel N, Duggleby RG, Windmill KF, Martin JL, McManus ME. Human sulfotransferases and their role in chemical metabolism. Toxicol Sci 2006;90:5-22.
65. Nardini M, Cirillo E, Natella F, Scaccini C. Absorption of phenolic acids in humans after coffee consumption. J Agric Food Chem 2002; 50:5735-41.
66. Mennen LI, Sapinho D, Ito H, Bertrais S, Galan P, Hercberg S, Scalbert A. Urinary flavonoids and phenolic acids as biomarkers of intake for polyphenol-rich foods. Br J Nutr 2006;96:191-8.
67. Altmaier E, Kastenmüller G, Römisch-MarglW, Thorand B, Weinberger KM, Adamski J, Illig T, Döring A, Suhre K. Variation in the human lipidome associated with coffee consumption as revealed by quantitative targeted metabolomics. Mol Nutr Food Res 2009;53:1357-65.